ACCU-CHEK ® AVIVA TEST STRIPS
Report
- Report Number
- 1823260-2010-04863
- Event Type
- Malfunction
- Date Received
- August 16, 2010
- Date of Event
- August 11, 2010
- Report Date
- August 30, 2010
- Manufacturer
- ROCHE DIAGNOSTICS
- Product Code
- LFR
- PMA / PMN Number
- K043474
- Removal / Correction Number
- NA
- Product Problem
- Yes
- Report Source
- Manufacturer report
- Reporter Location
- PA, US
- Reporter Occupation
- PATIENT
Narratives
IT WAS UNKNOWN IF THE INITIAL REPORTER SENT REPORT TO THE FDA.
THE CUSTOMER ALLEGED A SIGNIFICANT BILIRUBIN INTERFERENCE WITH THE (B)(4) ACETAMINOPHEN APPLICATION. THE CUSTOMER RECEIVED A QUESTIONABLE RESULT FOR ACETAMINOPHEN ON THE ANALYTICAL P MODULE FOR ONE PATIENT SAMPLE COLLECTED FROM A TRANSPLANT PATIENT. THE DATE OF OCCURRENCE WAS NOT PROVIDED. THE INITIAL RESULT FOR ACETAMINOPHEN WAS 130 UMOL/L. THIS RESULT WAS REPORTED OUTSIDE THE LABORATORY. THE BILIRUBIN CONCENTRATION FOR THIS SAMPLE WAS ABOUT 300 UMOL/L. A URINE SAMPLE OBTAINED FROM THE PATIENT WAS TESTED BY (B)(6) AND NO ACETAMINOPHEN WAS DETECTED IN THIS URINE SAMPLE. THE PATIENT WAS TREATED WITH (NAC) N-ACETYL CYSTEINE DUE TO THE QUESTIONABLE ACETAMINOPHEN RESULT OF 130 UMOL/L. NO ADVERSE EVENT HAS BEEN ALLEGED REAGARDING THIS EVENT. THE ACETAMINOPHEN REAGENT LOT NUMBER WAS NOT PROVIDED.
CALLER REPORTED BLOOD GLUCOSE RESULTS OF 281 MG/DL AT 5:05PM, 217 MG/DL A HALF MINUTE LATER, 110 MG/DL A FEW SECONDS LATER, AND 135 MG/DL A FEW SECONDS LATER ON THE ACCU-CHEK SYSTEM. REPORTED NO ADVERSE EVENT RELATIVE TO DISCREPANCY. A REQUEST WAS MADE FOR THE RETURN OF THE METER AND STRIPS, REPLACEMENT SENT.
Devices
| Seq | Brand | Generic | Product Code | Manufacturer | Model | Lot | UDI-DI |
|---|---|---|---|---|---|---|---|
| 1 | ACCU-CHEK ® AVIVA TEST STRIPS | BLOOD GLUCOSE MONITORING TEST STRIPS | LFR | ROCHE DIAGNOSTICS | NA | 301983 |
Patients
| Seq | Age | Sex | Outcome | Treatment |
|---|---|---|---|---|
| 1 | 060 YR | LEVEMIR| NOVOLOG |